Lortab: Difference between revisions
Jump to navigation
Jump to search
(Created page with "'''Lortab''' is a hydrocodone/paracetamol drug marketed by Russ Pharmaceuticals to target a market niche between over-the-counter pain medications and the strongest pain r...") |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Lortab''' is a hydrocodone/paracetamol drug marketed by [[Russ Pharmaceuticals]] to target a | '''Lortab''' is a hydrocodone/paracetamol drug originally marketed by [[Russ Pharmaceuticals]] to target a niche between over-the-counter pain medications and the strongest pain relievers. The combination was approved for medical use in the United States in [[1982]] and Russ Pharmaceuticals was incorporated by [[Russ Maddox]] in [[1984]]. | ||
Lortab originally targeted oncology and post-surgery patients and likely users, but found greater success in the dental field. Maddox sold his company in [[1989]] for $28 million. | Lortab originally targeted oncology and post-surgery patients and likely users, but found greater success in the dental field. Maddox sold his company in [[1989]] for $28 million. | ||
[[Category:Pharmaceuticals]] | [[Category:Pharmaceuticals]] | ||
Latest revision as of 20:15, 5 September 2022
Lortab is a hydrocodone/paracetamol drug originally marketed by Russ Pharmaceuticals to target a niche between over-the-counter pain medications and the strongest pain relievers. The combination was approved for medical use in the United States in 1982 and Russ Pharmaceuticals was incorporated by Russ Maddox in 1984.
Lortab originally targeted oncology and post-surgery patients and likely users, but found greater success in the dental field. Maddox sold his company in 1989 for $28 million.